Boryung Corporation

KOSE:A003850 Stock Report

Market Cap: ₩661.3b

Boryung Past Earnings Performance

Past criteria checks 5/6

Boryung has been growing earnings at an average annual rate of 12.7%, while the Pharmaceuticals industry saw earnings growing at 7.8% annually. Revenues have been growing at an average rate of 13.6% per year. Boryung's return on equity is 10.3%, and it has net margins of 6.3%.

Key information

12.7%

Earnings growth rate

8.6%

EPS growth rate

Pharmaceuticals Industry Growth11.3%
Revenue growth rate13.6%
Return on equity10.3%
Net Margin6.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

Jan 10
Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

Recent updates

We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt

Sep 20
We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt

Earnings Not Telling The Story For Boryung Corporation (KRX:003850)

Aug 05
Earnings Not Telling The Story For Boryung Corporation (KRX:003850)

Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

Apr 06
Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Apr 28
A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Mar 17
Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Feb 27
Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 09
Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Jan 25
Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

Jan 10
Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Dec 23
If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Dec 08
Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Nov 23
Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Revenue & Expenses Breakdown

How Boryung makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSE:A003850 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24991,43061,995230,06053,328
30 Jun 24928,71864,579223,42252,073
31 Mar 24889,41652,254220,64150,585
31 Dec 23859,62640,203214,85447,286
30 Sep 23829,85428,267201,65641,603
30 Jun 23819,46338,284200,15441,415
31 Mar 23785,67942,063195,42740,249
31 Dec 22760,47641,894191,85841,705
30 Sep 22724,65953,911184,42243,444
30 Jun 22694,17052,524178,67641,373
31 Mar 22661,94834,380173,97240,604
31 Dec 21627,27943,044171,81839,146
30 Sep 21600,00841,823167,98536,053
30 Jun 21587,35028,892167,01135,884
31 Mar 21571,59438,370159,08336,957
31 Dec 20561,86726,856148,22435,506
30 Sep 20562,43327,744144,70436,253
30 Jun 20546,97427,969140,38339,247
31 Mar 20539,74231,678140,14136,934
31 Dec 19524,26932,222139,54437,864
30 Sep 19498,00632,950127,56036,683
30 Jun 19480,24229,886124,85534,458
31 Mar 19467,44522,830125,22135,580
31 Dec 18460,40220,307122,20434,433
30 Sep 18441,58064,630107,69558,302
30 Jun 18440,08762,855115,35949,298
31 Mar 18434,56560,451127,96332,997
31 Dec 17422,72156,699127,66632,277
30 Sep 17426,554-3,202145,0237,366
30 Jun 17423,777-2,977137,32814,638
31 Mar 17420,1335,020120,81929,164
31 Dec 16409,1405,614121,77828,963

Quality Earnings: A003850 has high quality earnings.

Growing Profit Margin: A003850's current net profit margins (6.3%) are higher than last year (3.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A003850's earnings have grown by 12.7% per year over the past 5 years.

Accelerating Growth: A003850's earnings growth over the past year (119.3%) exceeds its 5-year average (12.7% per year).

Earnings vs Industry: A003850 earnings growth over the past year (119.3%) exceeded the Pharmaceuticals industry 20.8%.


Return on Equity

High ROE: A003850's Return on Equity (10.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies